HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gary H Lyman Selected Research
Gary H Lyman Research Topics
Disease
169
Neoplasms (Cancer)
04/2022 - 01/2002
73
Febrile Neutropenia
01/2022 - 01/2002
54
Breast Neoplasms (Breast Cancer)
08/2022 - 07/2003
52
Neutropenia
10/2021 - 01/2002
29
Infections
02/2022 - 01/2002
24
Venous Thromboembolism
10/2020 - 12/2005
16
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2021 - 07/2003
15
Hemorrhage
10/2020 - 09/2007
13
Thrombosis (Thrombus)
01/2020 - 01/2006
12
COVID-19
02/2022 - 09/2020
10
Anemia
01/2022 - 01/2004
9
Lymphoma (Lymphomas)
01/2016 - 04/2002
8
Ovarian Neoplasms (Ovarian Cancer)
10/2018 - 01/2004
7
Neoplasm Metastasis (Metastasis)
01/2021 - 06/2009
7
Venous Thrombosis (Deep-Vein Thrombosis)
01/2019 - 09/2007
6
Lung Neoplasms (Lung Cancer)
10/2020 - 10/2007
6
Fever (Fevers)
11/2016 - 04/2002
5
Pain (Aches)
08/2021 - 04/2002
5
Thromboembolism
01/2020 - 01/2006
5
Nausea
01/2019 - 07/2015
5
Colorectal Neoplasms (Colorectal Cancer)
09/2017 - 10/2007
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2015 - 12/2008
4
Chemotherapy-Induced Febrile Neutropenia
04/2021 - 10/2004
4
Multiple Myeloma
01/2020 - 06/2013
4
Pulmonary Embolism
01/2018 - 06/2013
4
Vomiting
01/2018 - 07/2015
3
Hematologic Neoplasms (Hematological Malignancy)
03/2022 - 07/2006
3
Carcinoma (Carcinomatosis)
01/2021 - 06/2012
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 12/2020
3
Sepsis (Septicemia)
01/2021 - 11/2005
3
Urogenital Neoplasms
10/2020 - 10/2007
3
Noninfiltrating Intraductal Carcinoma (DCIS)
02/2017 - 02/2007
3
Heart Failure
05/2014 - 01/2004
3
Overweight
08/2013 - 12/2003
3
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2011 - 12/2004
2
Thrombocytopenia (Thrombopenia)
01/2022 - 09/2020
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 09/2002
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2020 - 03/2012
Drug/Important Bio-Agent (IBA)
39
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
04/2022 - 04/2002
29
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
10/2021 - 04/2002
20
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2022 - 09/2003
18
Anticoagulants
IBA
01/2021 - 09/2007
15
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
01/2021 - 09/2007
13
Anti-Bacterial Agents (Antibiotics)
IBA
01/2022 - 11/2003
11
pegfilgrastim (Neulasta)
FDA Link
04/2017 - 07/2004
10
Biosimilar Pharmaceuticals
IBA
08/2022 - 09/2011
10
Filgrastim (Neupogen)
FDA Link
01/2021 - 01/2002
8
Rivaroxaban
IBA
10/2020 - 11/2017
7
Trastuzumab (Herceptin)
FDA Link
08/2022 - 11/2016
7
Estrogen Receptors
IBA
01/2019 - 05/2005
7
Anthracyclines
IBA
10/2018 - 10/2007
6
Platinum
IBA
01/2021 - 10/2007
6
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2017 - 12/2003
6
Hemoglobins (Hemoglobin)
IBA
05/2008 - 12/2003
5
Immune Checkpoint Inhibitors
IBA
01/2021 - 01/2018
5
Carboplatin (JM8)
FDA Link
Generic
01/2021 - 01/2015
5
Doxorubicin (Adriamycin)
FDA Link
Generic
04/2017 - 12/2003
5
Docetaxel (Taxotere)
FDA Link
04/2017 - 06/2014
4
Pharmaceutical Preparations
IBA
10/2020 - 10/2013
4
Dexamethasone (Maxidex)
FDA Link
Generic
01/2020 - 06/2013
4
Antiemetics
IBA
01/2020 - 07/2015
4
Erythropoietin
FDA Link
10/2008 - 01/2004
3
Tyrosine Kinase Inhibitors
IBA
01/2021 - 12/2020
3
Topotecan (Hycamtin)
FDA Link
Generic
01/2021 - 01/2004
3
Biological Products
IBA
01/2021 - 01/2020
3
Lenalidomide (CC 5013)
FDA Link
01/2020 - 12/2007
3
Dalteparin (Dalteparin Sodium)
FDA Link
08/2019 - 03/2017
3
Tamoxifen
FDA Link
Generic
10/2013 - 05/2005
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
03/2022 - 10/2020
2
Albumins
IBA
01/2022 - 01/2021
2
COVID-19 Vaccines
IBA
01/2022 - 03/2021
2
Vaccines
IBA
03/2021 - 01/2021
2
human ERBB2 protein
IBA
01/2021 - 10/2016
2
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 07/2015
2
Imatinib Mesylate (Gleevec)
FDA Link
01/2021 - 12/2020
2
Immunologic Factors (Immunomodulators)
IBA
01/2021 - 12/2004
2
Antineoplastic Agents (Antineoplastics)
IBA
01/2021 - 10/2017
2
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
10/2020 - 01/2020
2
Heparin (Liquaemin)
FDA Link
Generic
10/2020 - 10/2013
2
edoxaban
IBA
10/2020 - 08/2019
2
apixaban
IBA
10/2020 - 01/2020
2
Thalidomide (Thalomid)
FDA Link
01/2020 - 12/2007
2
Immunomodulating Agents
IBA
01/2020 - 01/2019
Therapy/Procedure
152
Drug Therapy (Chemotherapy)
03/2022 - 01/2002
51
Therapeutics
03/2022 - 11/2003
12
Adjuvant Chemotherapy
01/2021 - 12/2003
11
Drug Tapering
10/2021 - 11/2003
5
Length of Stay
01/2022 - 11/2005
5
Neoadjuvant Therapy
01/2021 - 05/2014
4
Treatment Delay
10/2021 - 11/2004
4
Immunotherapy
01/2021 - 01/2018
4
Precision Medicine
12/2019 - 06/2011
4
Lymph Node Excision (Lymph Node Dissection)
02/2018 - 05/2014
3
Ambulatory Care (Outpatient Care)
01/2022 - 06/2014
3
Radiotherapy
01/2021 - 11/2011
3
Secondary Prevention
01/2018 - 12/2009
3
Segmental Mastectomy (Lumpectomy)
02/2017 - 05/2014
3
Injections
12/2005 - 01/2002
2
Standing Orders
04/2022 - 11/2019
2
Hospice Care (Care, Bereavement)
01/2022 - 01/2018